Atricure Stock Performance

ATRC Stock  USD 36.80  1.27  3.34%   
On a scale of 0 to 100, AtriCure holds a performance score of 7. The firm shows a Beta (market volatility) of 1.46, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AtriCure will likely underperform. Please check AtriCure's treynor ratio, kurtosis, relative strength index, as well as the relationship between the downside variance and day median price , to make a quick decision on whether AtriCure's price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in AtriCure are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, AtriCure exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
(3.34)
Five Day Return
(0.41)
Year To Date Return
(6.29)
Ten Year Return
117.24
All Time Return
161.36
1
AtriCure Is Down 5.8 percent After Raising Revenue Guidance and Narrowing Net Loss Has The Bull Case Changed
11/10/2025
2
Disposition of 5033 shares by Wehrwein Sven of AtriCure at 19.95 subject to Rule 16b-3
11/24/2025
3
Justin Noznesky Sells 5,166 Shares of AtriCure Stock
11/28/2025
4
Disposition of 4000 shares by Michael Carrel of AtriCure subject to Rule 16b-3
12/10/2025
5
How supply chain issues affect AtriCure Inc. stock - Market Risk Report Fast ExitEntry Strategy Plans -
12/18/2025
6
Acquisition by Douglas Seith of 257 shares of AtriCure at 27.37 subject to Rule 16b-3
12/31/2025
7
Head to Head Survey Hero Technologies vs. AtriCure
01/05/2026
8
AtriCure stock hits 52-week high at 43.18 - Investing.com
01/08/2026
9
AtriCure Reports Strong Preliminary 2025 Revenue Growth - The Globe and Mail
01/13/2026
10
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results
01/16/2026
11
AtriCure Is Up 5.1 percent After Raising 2026 Guidance And Refinancing Credit Facility - Has The Bull Case Changed
01/22/2026
12
ISRGs da Vinci Gets FDA Nod for Advanced Cardiac Procedures
01/27/2026
13
QT Imaging Olea Medical Partner to Enhance Cloud Imaging Platform
01/28/2026
14
Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves
02/04/2026
Begin Period Cash Flow84.3 M
Total Cashflows From Investing Activities30.2 M

AtriCure Relative Risk vs. Return Landscape

If you would invest  3,150  in AtriCure on November 6, 2025 and sell it today you would earn a total of  530.00  from holding AtriCure or generate 16.83% return on investment over 90 days. AtriCure is currently generating 0.3072% in daily expected returns and assumes 3.2652% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than AtriCure, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days AtriCure is expected to generate 4.37 times more return on investment than the market. However, the company is 4.37 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

AtriCure Target Price Odds to finish over Current Price

The tendency of AtriCure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 36.80 90 days 36.80 
about 60.44
Based on a normal probability distribution, the odds of AtriCure to move above the current price in 90 days from now is about 60.44 (This AtriCure probability density function shows the probability of AtriCure Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.46 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, AtriCure will likely underperform. Additionally AtriCure has an alpha of 0.0783, implying that it can generate a 0.0783 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   AtriCure Price Density   
       Price  

Predictive Modules for AtriCure

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AtriCure. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
34.0037.2740.54
Details
Intrinsic
Valuation
LowRealHigh
33.1243.0446.31
Details
Naive
Forecast
LowNextHigh
33.2536.5239.78
Details
9 Analysts
Consensus
LowTargetHigh
48.0352.7858.58
Details

AtriCure Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. AtriCure is not an exception. The market had few large corrections towards the AtriCure's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AtriCure, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AtriCure within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.08
β
Beta against Dow Jones1.46
σ
Overall volatility
3.21
Ir
Information ratio 0.03

AtriCure Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AtriCure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AtriCure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
AtriCure had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 465.31 M. Net Loss for the year was (44.7 M) with profit before overhead, payroll, taxes, and interest of 388.06 M.
AtriCure has a frail financial position based on the latest SEC disclosures
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Azenta director Alan P. Malus resigns from board for new full-time role - Investing.com

AtriCure Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AtriCure Stock often depends not only on the future outlook of the current and potential AtriCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AtriCure's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding47 M
Cash And Short Term Investments122.7 M

AtriCure Fundamentals Growth

AtriCure Stock prices reflect investors' perceptions of the future prospects and financial health of AtriCure, and AtriCure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AtriCure Stock performance.

About AtriCure Performance

By analyzing AtriCure's fundamental ratios, stakeholders can gain valuable insights into AtriCure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AtriCure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AtriCure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 210.11  133.18 
Return On Tangible Assets(0.14)(0.13)
Return On Capital Employed(0.07)(0.07)
Return On Assets(0.07)(0.07)
Return On Equity(0.09)(0.09)

Things to note about AtriCure performance evaluation

Checking the ongoing alerts about AtriCure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AtriCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
AtriCure had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 465.31 M. Net Loss for the year was (44.7 M) with profit before overhead, payroll, taxes, and interest of 388.06 M.
AtriCure has a frail financial position based on the latest SEC disclosures
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Azenta director Alan P. Malus resigns from board for new full-time role - Investing.com
Evaluating AtriCure's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate AtriCure's stock performance include:
  • Analyzing AtriCure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AtriCure's stock is overvalued or undervalued compared to its peers.
  • Examining AtriCure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating AtriCure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AtriCure's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of AtriCure's stock. These opinions can provide insight into AtriCure's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating AtriCure's stock performance is not an exact science, and many factors can impact AtriCure's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
FinTech Suite
Use AI to screen and filter profitable investment opportunities